A/Prof Gurbakhash Kaur is a board-certified hematologist-oncologist specialising in multiple myeloma and plasma cell disorders at Mount Sinai Hospital, New York City. She completed her medical degree at Drexel University, followed by residency at Tufts Medical Center and fellowship training at Montefiore Medical Center/Albert Einstein College of Medicine. Her research and clinical focus includes studying optimal drug dosing strategies for standard myeloma therapies, CAR-T cells and bispecific antibodies in multiple myeloma.